Company news
Aptorum Group Limited news in 2019
Aptorum Group Limited's news releases, calls and decks from 2019, newest first.
Aptorum Group Limited Announces Results of 2019 Annual General Meeting
November 14, 2019
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA
September 9, 2019
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
September 8, 2019